Cargando…

Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia

Detalles Bibliográficos
Autores principales: Nguyen, Katarina T., Gwinn, Courtney C., Vary, Jay C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992878/
https://www.ncbi.nlm.nih.gov/pubmed/32016156
http://dx.doi.org/10.1016/j.jdcr.2019.12.007
_version_ 1783492921119473664
author Nguyen, Katarina T.
Gwinn, Courtney C.
Vary, Jay C.
author_facet Nguyen, Katarina T.
Gwinn, Courtney C.
Vary, Jay C.
author_sort Nguyen, Katarina T.
collection PubMed
description
format Online
Article
Text
id pubmed-6992878
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69928782020-02-03 Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia Nguyen, Katarina T. Gwinn, Courtney C. Vary, Jay C. JAAD Case Rep Case Report Elsevier 2020-01-22 /pmc/articles/PMC6992878/ /pubmed/32016156 http://dx.doi.org/10.1016/j.jdcr.2019.12.007 Text en © 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Nguyen, Katarina T.
Gwinn, Courtney C.
Vary, Jay C.
Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
title Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
title_full Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
title_fullStr Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
title_full_unstemmed Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
title_short Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
title_sort rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992878/
https://www.ncbi.nlm.nih.gov/pubmed/32016156
http://dx.doi.org/10.1016/j.jdcr.2019.12.007
work_keys_str_mv AT nguyenkatarinat rituximabtreatmentfordermatitisherpetiformisinthesettingoftype1diabetesmellitusceliacdiseasevitiligoautoimmunehemolyticanemiaandautoimmunethrombocytopenia
AT gwinncourtneyc rituximabtreatmentfordermatitisherpetiformisinthesettingoftype1diabetesmellitusceliacdiseasevitiligoautoimmunehemolyticanemiaandautoimmunethrombocytopenia
AT varyjayc rituximabtreatmentfordermatitisherpetiformisinthesettingoftype1diabetesmellitusceliacdiseasevitiligoautoimmunehemolyticanemiaandautoimmunethrombocytopenia